Table 3.
Overall PPV attendance estimate | ||||
---|---|---|---|---|
N | Mean percentage across studies | IQR | Range | |
Study characteristic | ||||
Total | ||||
Number of participants | 82† | 72.1 | 60.3–88.2 | 24.9–96.5 |
Under 100 | 7 | 61.7 | 52.5–71.4 | 48.0–73.4 |
100–299 | 6 | 70.6 | 52.3–84.5 | 40.1–95.4 |
300–799 | 19 | 69.4 | 61.0–82.0 | 30.0–92.9 |
800–6200 | 22 | 76.9 | 63.9–90.0 | 24.9–94.2 |
6200+ | 26 | 72.0 | 49.5–89.4 | 39.6–96.5 |
Data source | ||||
Health insurance claims | 18 | 56.5 | 40.3–67.1 | 24.9–85.7 |
Electronic health record | 18 | 70.5 | 61.5–82 | 40.1–92.9 |
Medical chart review/abstraction | 17 | 65.8 | 57.3–73.4 | 30.0–96.5 |
Patient survey | 27 | 88 | 86.7–90.7 | 67.6–95.4 |
Other | 2 | 66.5 | n/a | 60.1–72.8 |
Year of publication | ||||
1995–2000 | 1 | 83 | n/a | n/a |
2001–2005 | 6 | 68.9 | 71.0–73.4 | 37.9–85.0 |
2006–2010 | 8 | 86.0 | 81.8–90.2 | 72.3–96.5 |
2011–2015 | 20 | 79.0 | 65.9–90.0 | 48.0–95.4 |
2016–2020 | 47 | 67.0 | 52.3–85.7 | 24.9–92.9 |
Study population type | ||||
Single hospital or healthcare system | 33 | 69.5 | 61.5–80.2 | 30.0–95.4 |
Defined set of clinics | 5 | 78.9 | 73.0–87.0 | 71.4–88.1 |
Single health plan | 16 | 62.7 | 49.4–82.0 | 40.0–96.5 |
Population-based, single state | 5 | 90.7 | 89.6–92.9 | 86.7–94.2 |
Population-based, multiple states | 9 | 89.4 | 88.7–90.1 | 85.9–92.3 |
Nationally drawn | 5 | 81.1 | 72.8–90.0 | 67.6–90.1 |
Other | 9 | 62.3 | 39.6–88.9 | 24.9–91.7 |
Study population | ||||
Medicaid insured | 15 | 64.7 | 49.4–82.9 | 37.9 – 85.7 |
Commercially insured | 4 | 58.5 | 40.2–76.9 | 40.0–96.5 |
Healthy Start | 2 | 88.8 | n/a | 86.5 – 91.0 |
Hispanic/Latinx | 3 | 72.5 | n/a | 71.0–73.4 |
Adolescent | 4 | 72.7 | 66.3–79.1 | 61.5–85.9 |
Predominantly but not specificallylimited to low-income, uninsured, Medicaid insured, or other underserved sociodemographic group | 14 | 77.1 | 71.4–86.5 | 61.5–88.9 |
Diabetes | 12 | 70.8 | 57.8–82.5 | 39.6–96.5 |
Hypertensive disorders of pregnancy | 2 | 46.3 | n/a | n/a |
Medically high risk but not single condition-specific | 3 | 81.3 | n/a | 73.4–95.4 |
Preterm birth or low birthweight | 2 | 68.5 | n/a | 52.5–84.5 |
Substance use disorder | 5 | 41.6 | 37.9–42.8 | 30.0–57.3 |
People living with HIV/AIDS | 4 | 66.3 | 54.7–78.0 | 37.9–79.9 |
Specific contraceptive plan | 5 | 65.5 | 61.5–63.9 | 48.0–92.3 |
Abbreviations: postpartum visit, PPV; interquartile range, IQR; human immunodeficiency virus, HIV; acquired immunodeficiency syndrome, AIDS
6 studies did not provide an estimate of postpartum visit attendance for the full study population.